Neurogenic inhibitory action through platelets of platelet activating factor (PAF) on vasoconstrictive responsiveness to pressor agents.
Michibayashi
T
T
Department of Laboratory Diagnosis, Faculty of Medicine, Sapporo Medical University, Japan.
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D008297:Male; D019335:Nitroarginine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology*; D010477:Perfusion; D010972:Platelet Activating Factor / Q000494:pharmacology*; D011817:Rabbits; D013779:Tetrodotoxin / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D010972:Platelet Activating Factor; D014662:Vasoconstrictor Agents; D019335:Nitroarginine; D013779:Tetrodotoxin; D009638:Norepinephrine